Compare CTKB & MG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTKB | MG |
|---|---|---|
| Founded | 1990 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Military/Government/Technical |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 541.1M | 531.0M |
| IPO Year | 2021 | 2008 |
| Metric | CTKB | MG |
|---|---|---|
| Price | $4.89 | $19.73 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.63 | N/A |
| AVG Volume (30 Days) | ★ 764.1K | 218.1K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.30 |
| Revenue | $193,015,000.00 | ★ $700,970,000.00 |
| Revenue This Year | $5.42 | $5.47 |
| Revenue Next Year | $7.03 | $3.59 |
| P/E Ratio | ★ N/A | $65.53 |
| Revenue Growth | ★ 17.67 | N/A |
| 52 Week Low | $3.28 | $9.35 |
| 52 Week High | $6.18 | $20.20 |
| Indicator | CTKB | MG |
|---|---|---|
| Relative Strength Index (RSI) | 58.91 | 59.54 |
| Support Level | $4.17 | $18.17 |
| Resistance Level | $5.24 | $20.20 |
| Average True Range (ATR) | 0.20 | 0.65 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 75.93 | 77.65 |
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International, and Products and Systems, of which key revenue is derived from the North America segment. The North America segment provides asset protection solutions, including NDT, inspection, and mechanical and engineering services, along with software, digital, and data services.